About Infigo Eyecare
Infigo Eyecare is a Healthcare company based in Mumbai (India) founded in 2018 by Anil Kamath and Shridhar Thakur, and was acquired by IIFL Finance in June 2019. Chain of eye care clinics. Infigo Eyecare has raised $5.83 million across 1 funding round from investors including IIFL Finance and 360 One. The company has 38 employees. Its chief executive, as recorded, is Shridhar Thakur. Its Indian entity Infigo Lifesciences Private Limited reported revenue of ₹22.76 Cr. Infigo Eyecare offers products and services including Cataract Surgery, Glaucoma Treatment, Diabetic Retinopathy Care, and Retinal Examination. Its focus areas include Clinic Chains, Specialty Clinics and Eye Care. Its competitors include Ramkrishna Netralaya, Dekhon and Swaraashi Netralaya.
Company details
Infigo Eyecare was established in 2018 in Mumbai, India, as a chain of eye care clinics. Operations are centered on delivering eye care services within the healthcare sector. The company is led by co-founders Anil Kamath and Shridhar Thakur, with Thakur designated as CEO. Its online presence is maintained via the domain infigoeye.com, supporting clinic activities in the region.
- Headquarters Mumbai, India
- Employees 38
- Founders Anil Kamath, Shridhar Thakur
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website infigoeye.com
- Social LinkedIn Facebook Instagram YouTube
- Acquired by IIFL Finance (Jun 2019)
- Legal Name Infigo Lifesciences Private Limited
- Date of Incorporation 26 Sep, 2017
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹22.76 Cr
FY 2026 · +3% YoY
- Net Loss-₹2.21 Cr
FY 2026 · -10% margin
- EBITDA₹45.7 Lakh
FY 2026 · 2% margin
- Total Equity Funding$5.83M (USD)
in 1 rounds
- Latest Funding Round$5.83M (USD), Series A
Aug 2018
- InvestorsIIFL Finance
& 1 more
- Employee Count38
- Acquired byIIFL Finance
(Jun 2019)
Associated legal entities of Infigo Eyecare
Infigo Eyecare operates through Infigo Lifesciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Infigo Lifesciences Private Limited CIN U74999MH2017PTC300119 | Active | 26 Sep 2017 | Mumbai, Maharashtra | ₹22.8 Cr | 98 | 3 | View details |
Products & Services of Infigo Eyecare
Infigo Eyecare offers a comprehensive portfolio of products and services, including Cataract Surgery, Glaucoma Treatment, Diabetic Retinopathy Care, and Retinal Examination.
Procedure to remove cloudy lens for improved vision clarity.
Therapies to control eye pressure and prevent vision loss.
Treatments for diabetes-related eye damage to maintain sight.
Comprehensive tests to detect and monitor retinal conditions.
Apps and channels of Infigo Eyecare
its YouTube channel INFIGO EYE CARE HOSPITAL has 1.09K subscribers and 30 videos.
Videos from Infigo Eyecare
The most watched videos on Infigo Eyecare's YouTube channel, INFIGO EYE CARE HOSPITAL (1.09K subscribers). Click a video to play it here.
More on INFIGO EYE CARE HOSPITAL.
Funding Insights of Infigo Eyecare
Infigo Eyecare has successfully raised a total of $5.83M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.83 million completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.83M
- Total Rounds 1
- Last Round Series A — $5.83M
- First Round $5.83M
(Aug 2018)
- Investors Count 1
All 1 funding rounds of Infigo Eyecare with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2018 | $5.83M | Series A | – | 360 One | – |
2 investors in total: 2 institutional.
Investors in Infigo Eyecare
Infigo Eyecare has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include IIFL Finance and 360 One.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Asset and wealth management software is provided for businesses. | 2008 | 360.one | Mumbai, India | |
Online gold, home, personal, and business loans are provided. | 1995 | iifl.com | Mumbai, India |
Investor details for Infigo Eyecare
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Infigo Lifesciences Private Limited (Infigo Eyecare)
Infigo Lifesciences Private Limited is the primary company behind Infigo Eyecare. The board of Infigo Lifesciences Private Limited currently have 2 directors; the longest-serving is Shridhar Thakur Raghunath, appointed in 2017. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shridhar Thakur Raghunath DIN 07928029 | Managing Director | 26 Sep 2017 | 9 yrs 1 mo | Infigo Lifesciences Private Limited |
| Anil Vasudev Kamath DIN 00015706 | Director | 26 Sep 2017 | 9 yrs 1 mo | Infigo Lifesciences Private Limited |
People of Infigo Eyecare
2 people are tracked at Infigo Eyecare (2 in leadership); the tracked headcount is 38.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder & CEO | Leadership |
Complete people profiles for Infigo Eyecare
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Infigo Eyecare
Figures of Infigo Lifesciences Private Limited, the primary company behind Infigo Eyecare, for FY 2026. Revenue was ₹22.76 Cr (+3% year on year). Net loss was -₹2.21 Cr (-10% margin). EBITDA was ₹45.7 Lakh (2% margin). Revenue has grown at a compounded annual rate of +9% over three years and +22% over five years.
- ₹22.76 CrRevenue · FY 2026 · +3% YoY
- -₹2.21 CrNet loss · -10% margin
- ₹45.7 LakhEBITDA · 2% margin
- ₹78.3 LakhPaid-up capital
- 98Employees (provident fund records)
- +9%Revenue CAGR, 3 years
- +22%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Infigo Lifesciences Private Limited are on its company page.
Detailed financial statements for Infigo Eyecare
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Infigo Eyecare
3 dated milestones of Infigo Eyecare across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Infigo Eyecare is founded.
- Funding First funding round of $5.8M.
- Exit Acquired by IIFL Finance.
Competitors of Infigo Eyecare
Infigo Eyecare has 3 listed competitors in our database. They include Ramkrishna Netralaya, Dekhon and Swaraashi Netralaya.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| shreeramkrishnanetralaya.com | 2006 | Thane, India | Offers specialized eye surgeries for cataract, glaucoma, and vision correction. | |||
| dekhon.org | 2011 | Jalna, India | Offers eye care services, outreach, and donations to communities in India. | |||
| swaraashinetralaya.in | 2017 | Mumbai, India | Operates a chain of eye care clinics providing specialized medical services. |
Detailed competitors of Infigo Eyecare
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Hospitals & Clinical Care
3 companies that operate in the same segment as Infigo Eyecare (Hospitals & Clinical Care) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Maternity, childcare, and fertility services are delivered via hospital chains. | 2007 | Bengaluru, Karnataka, India | USD 204.87 M | USD 140.46 M | 4,459 | |
Chain of oncology hospitals | 1989 | Bengaluru, Karnataka, India | USD 36.59 M | USD 270.51 M | 321 | |
Chain of multi-super specialty healthcare hospitals | 2004 | Gurugram, Haryana, India | USD 104.7 M | USD 461.72 M | 12,240 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Infigo Eyecare
Complete news archive for Infigo Eyecare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Infigo Eyecare
Infigo Eyecare was founded in 2018.
Infigo Eyecare is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Shridhar Thakur is the CEO of Infigo Eyecare, as recorded in our data. They have also founded this company.
Infigo Eyecare is a funded company, having raised a total of $5.83M across 1 funding round to date. The company's 1st funding round was a Series A of $5.83M, raised on Aug 2018.
Infigo Eyecare has 38 employees.
The primary company behind Infigo Eyecare, Infigo Lifesciences Private Limited, reported revenue of ₹22.76 Cr for FY 2026, up 3% year on year.
Infigo Eyecare was established in 2018 in Mumbai, India, as a chain of eye care clinics. Operations are centered on delivering eye care services within the healthcare sector. The company is led by co-founders Anil Kamath and Shridhar Thakur, with Thakur designated as CEO. Its online presence is maintained via the domain infigoeye.com, supporting clinic activities in the region.
Infigo Eyecare's top competitors include Ramkrishna Netralaya, Dekhon and Swaraashi Netralaya.
Infigo Eyecare offers Cataract Surgery, Glaucoma Treatment, Diabetic Retinopathy Care, and Retinal Examination.
Infigo Eyecare has 2 investors. Key investors include IIFL Finance, and 360 One.
Infigo Eyecare operates through Infigo Lifesciences Private Limited.
Yes. Infigo Eyecare was acquired by IIFL Finance in June 2019.